Aug 2026· Research Square· 0 citations· 20 references
Medicine
TL;DR
11 visuospatial subtests of existing cognitive measures are demonstrated to be good candidates for clinical trial outcome measures in KS1, consistent with previous literature that visuospatial deficits are prominent in KS individuals and disproportionate to their intelligence quotient (IQ).
Abstract
Background Kabuki syndrome type 1 (KS1) is a rare genetic neurodevelopmental disability syndrome characterized by significant weaknesses in visuospatial cognitive processes in comparison to other cognitive domains. There is a great unmet need for validated and specific cognitive outcome measures for clinical trials in patients with KS1. This study evaluated the validity and reliability of a Kabuki Syndrome Cognitive Assessment Battery (KS-CAB), a visuospatial assessment that is specific to KS1. Twenty-two individuals with molecularly confirmed KS1 (mean age = 21.1 years, range = 12.5–36.1 years) completed the same cognitive battery on two separate days. Results Individuals with KS1 demonstrated consistent deficits in visuospatial cognition domains (often > 3 standard deviations below the mean), whereas other cognitive domains, such as language and executive functioning, were more variable. All visuospatial measures comprising the KS-CAB exhibited high test– retest reliability (Cronbach’s alpha = 0.81–0.97; intraclass correlation coefficient = 0.71–0.94). Subgroup analyses revealed that participants with missense variants outperformed those with truncating variants in visuospatial tasks. Conclusions These findings are consistent with previous literature that visuospatial deficits are prominent in KS individuals and disproportionate to their intelligence quotient (IQ). In addition, this study demonstrated the reliability of 11 visuospatial subtests of existing cognitive measures, suggesting these are good candidates for clinical trial outcome measures in KS1.
Those with KS2 showed greater difficulties across all social behavior/cognitive domains than KS1 counterparts, albeit both presented with similar severity in RRB and prosocial behaviors.
Rowena Ng, P. Fanara, Lauren Meier et al.· Archives of Clinical Neurops...· 0 citations
BACKGROUND
People with Down syndrome (DS) have intellectual disability and a distinct neuroanatomy due to genetic-induced atypical neurodevelopment. Although a few previous studies have shown increased cortical thickness (CT) in this syndrome, their functional impact remains to be investigated. Here we addressed this q...
L. Jorge, Joana Oliveira, N. Canário et al.· Acta Psychologica· 0 citations
The CCAS scale predicted postoperative outcomes in non-pain domains and captured cognitive brain processing within a network that aligns with established neuropsychological instruments and support CCAS as a valid complementary cognitive assessment tool.
N. Amaral-Nieves, B. Shao, Mei E. Tiemeyer et al.· Cerebellum· 0 citations
Improvements in group-level performance improved in six of the twenty tests administered, of which three remained significant after correction for multiple comparisons, while 28 of 42 patients (66.7%) still scored in the impaired range on at least one test at 12 months, and 17 (40.5%) on two or more.
Giulia Del Duca, M. Camici, Isabella Sperduti et al.· Neurology International· 0 citations
These exploratory findings suggest cognitive and affective alterations in SCA6 beyond the motor domain, warranting investigation within the Cerebellar Cognitive Affective Syndrome framework.
Fernanda Mary Machado, B. Massuyama, J. S. Gomes et al.· Cerebellum· 0 citations
Abstract Background 22q11.2 deletion syndrome (22q11DS) is strongly associated with aberrant neurodevelopment, including decreased cognitive functioning and schizophrenia spectrum disorders (SSDs). While the different core domains of IQ have distinct clinical ramifications, their collective profile has not been well-ch...
A. Fiksinski, Rielle Wierenga, D. McDonald-McGinn et al.· Psychological Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.